Switch theme
Sign up to access all valuation multiples
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer”, although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
1998
1.4K+
LTM Revenue $4.5B
LTM EBITDA $260M
$8.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Alibaba Health has a last 12-month revenue of $4.5B and a last 12-month EBITDA of $260M.
In the most recent fiscal year, Alibaba Health achieved revenue of $3.5B and an EBITDA of $128M.
Alibaba Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Alibaba Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $3.4B | $3.5B | XXX | XXX | XXX |
| Gross Profit | $528M | $733M | XXX | XXX | XXX |
| Gross Margin | 15% | 21% | XXX | XXX | XXX |
| EBITDA | $79.8M | $128M | XXX | XXX | XXX |
| EBITDA Margin | 2% | 4% | XXX | XXX | XXX |
| Net Profit | -$34.2M | $68.6M | XXX | XXX | XXX |
| Net Margin | -1% | 2% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Alibaba Health's stock price is HKD 5 (or $1).
Alibaba Health has current market cap of HKD 75.1B (or $9.7B), and EV of HKD 67.0B (or $8.6B).
See Alibaba Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.6B | $9.7B | XXX | XXX | XXX | XXX | $0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Alibaba Health has market cap of $9.7B and EV of $8.6B.
Alibaba Health's trades at 2.1x LTM EV/Revenue multiple, and 35.5x LTM EBITDA.
Analysts estimate Alibaba Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Alibaba Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $8.6B | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 40.6x | XXX | XXX | XXX |
| P/E | 45.7x | XXX | XXX | XXX |
| P/E/Growth | 1.3x | XXX | XXX | XXX |
| EV/FCF | 52.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAlibaba Health's NTM/LTM revenue growth is 12%
Alibaba Health's revenue per employee for the last fiscal year averaged $2.4M, while opex per employee averaged $0.5M for the same period.
Over next 12 months, Alibaba Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Alibaba Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Alibaba Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 61% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 18% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $2.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.5M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 19% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Alibaba Health acquired XXX companies to date.
Last acquisition by Alibaba Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Alibaba Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Alibaba Health founded? | Alibaba Health was founded in 1998. |
| Where is Alibaba Health headquartered? | Alibaba Health is headquartered in Hong Kong. |
| How many employees does Alibaba Health have? | As of today, Alibaba Health has 1.4K+ employees. |
| Who is the CEO of Alibaba Health? | Alibaba Health's CEO is Mr. Difan Shen. |
| Is Alibaba Health publicy listed? | Yes, Alibaba Health is a public company listed on HKG. |
| What is the stock symbol of Alibaba Health? | Alibaba Health trades under 00241 ticker. |
| When did Alibaba Health go public? | Alibaba Health went public in 1972. |
| Who are competitors of Alibaba Health? | Similar companies to Alibaba Health include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
| What is the current market cap of Alibaba Health? | Alibaba Health's current market cap is $9.7B |
| What is the current revenue of Alibaba Health? | Alibaba Health's last 12-month revenue is $4.5B. |
| What is the current EBITDA of Alibaba Health? | Alibaba Health's last 12-month EBITDA is $260M. |
| What is the current EV/Revenue multiple of Alibaba Health? | Current revenue multiple of Alibaba Health is 2.1x. |
| What is the current EV/EBITDA multiple of Alibaba Health? | Current EBITDA multiple of Alibaba Health is 35.5x. |
| What is the current revenue growth of Alibaba Health? | Alibaba Health revenue growth between 2023 and 2024 was 1%. |
| Is Alibaba Health profitable? | Yes, Alibaba Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
